FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801679898> ?p ?o ?g. }

• W2801679898 endingPage "241" @default.
• W2801679898 startingPage "236" @default.
• W2801679898 abstract "Background Pulmonary arterial smooth muscle cell (PASMC) proliferation is vital to pulmonary vascular remodeling in pulmonary arterial hypertension (PAH) pathogenesis, and inhibiting PASMC metabolism could serve as a new possible therapy to reverse the process. 3-Bromopyruvate (3-BrPA) is an effective glycolysis inhibitor with its effect in PAH remains unclear. Our study aims to assess the therapeutic effect of 3-BrPA in PAH rats and investigate the possible mechanism of 3-BrPA in PASMC proliferation and apoptosis. Methods 27 healthy SD rats were grouped and treated with hypoxia/normoxia and administration of 3-BrPA/physiological saline. Mean pulmonary artery pressure (mPAP) and cardiac output (CO) were measured and pulmonary vascular resistance (PVR) was calculated. Right ventricular hypertrophy index (RVHI) was calculated to evaluate the right ventricular hypertrophy degree. The percentage of medial wall area (WA%) and medial wall thickness (WT%) were measured by image analysis. PASMCs groups received hypoxia/normoxia treatments and 3-BrPA/physiological saline. PASMC proliferation and migration were respectively detected by CCK-8 and cell wound scratch assay. Hexokinase II (HK-2) expression and lactate level were respectively measured by Western Blotting and lactate test kit to detect glycolysis. Results mPAP, PVR, PVHI, WA% and WT% in rats increased after the hypoxia treatment, but were lower compared to rats received 3-BrPA in hypoxia environment. HK-2 expression, lactate concentration, OD value and scratch areas in PASMCs increased after the hypoxia treatment, but were decreased after the administration of 3-BrPA. Conclusion 3-BrPA can inhibit PASMC proliferation and migration by inhibiting glycolysis, and is effective in reversing the vascular remodeling in hypoxia–induced PAH rats." @default.
• W2801679898 created "2018-05-17" @default.
• W2801679898 creator A5048938906 @default.
• W2801679898 creator A5052308070 @default.
• W2801679898 creator A5070314365 @default.
• W2801679898 creator A5071963312 @default.
• W2801679898 creator A5089363979 @default.
• W2801679898 date "2018-09-01" @default.
• W2801679898 modified "2023-10-16" @default.
• W2801679898 title "3-Bromopyruvate reverses hypoxia-induced pulmonary arterial hypertension through inhibiting glycolysis: In vitro and in vivo studies" @default.
• W2801679898 cites W1482104242 @default.
• W2801679898 cites W1513949492 @default.
• W2801679898 cites W1557623591 @default.
• W2801679898 cites W1707983953 @default.
• W2801679898 cites W1961919749 @default.
• W2801679898 cites W1989998833 @default.
• W2801679898 cites W1994006335 @default.
• W2801679898 cites W1994255159 @default.
• W2801679898 cites W1999388852 @default.
• W2801679898 cites W1999477803 @default.
• W2801679898 cites W2020277250 @default.
• W2801679898 cites W2037970859 @default.
• W2801679898 cites W2039015357 @default.
• W2801679898 cites W2041507819 @default.
• W2801679898 cites W2042146535 @default.
• W2801679898 cites W2043828993 @default.
• W2801679898 cites W2052522225 @default.
• W2801679898 cites W2064162418 @default.
• W2801679898 cites W2065501812 @default.
• W2801679898 cites W2066166564 @default.
• W2801679898 cites W2077065151 @default.
• W2801679898 cites W2081651784 @default.
• W2801679898 cites W2084835859 @default.
• W2801679898 cites W2095096827 @default.
• W2801679898 cites W2112804584 @default.
• W2801679898 cites W2119127838 @default.
• W2801679898 cites W2130579537 @default.
• W2801679898 cites W2131299836 @default.
• W2801679898 cites W2156943914 @default.
• W2801679898 cites W2202999240 @default.
• W2801679898 cites W2205385475 @default.
• W2801679898 cites W2214739907 @default.
• W2801679898 cites W2288033263 @default.
• W2801679898 cites W2508109728 @default.
• W2801679898 cites W2520438147 @default.
• W2801679898 cites W2592714610 @default.
• W2801679898 cites W2604253534 @default.
• W2801679898 cites W2614800967 @default.
• W2801679898 doi "https://doi.org/10.1016/j.ijcard.2018.03.104" @default.
• W2801679898 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29735421" @default.
• W2801679898 hasPublicationYear "2018" @default.
• W2801679898 type Work @default.
• W2801679898 sameAs 2801679898 @default.
• W2801679898 citedByCount "17" @default.
• W2801679898 countsByYear W28016798982018 @default.
• W2801679898 countsByYear W28016798982019 @default.
• W2801679898 countsByYear W28016798982020 @default.
• W2801679898 countsByYear W28016798982021 @default.
• W2801679898 countsByYear W28016798982022 @default.
• W2801679898 countsByYear W28016798982023 @default.
• W2801679898 crossrefType "journal-article" @default.
• W2801679898 hasAuthorship W2801679898A5048938906 @default.
• W2801679898 hasAuthorship W2801679898A5052308070 @default.
• W2801679898 hasAuthorship W2801679898A5070314365 @default.
• W2801679898 hasAuthorship W2801679898A5071963312 @default.
• W2801679898 hasAuthorship W2801679898A5089363979 @default.
• W2801679898 hasConcept C126322002 @default.
• W2801679898 hasConcept C139940330 @default.
• W2801679898 hasConcept C150903083 @default.
• W2801679898 hasConcept C164705383 @default.
• W2801679898 hasConcept C178790620 @default.
• W2801679898 hasConcept C178853913 @default.
• W2801679898 hasConcept C185592680 @default.
• W2801679898 hasConcept C190283241 @default.
• W2801679898 hasConcept C20251656 @default.
• W2801679898 hasConcept C207001950 @default.
• W2801679898 hasConcept C2777397205 @default.
• W2801679898 hasConcept C2777714996 @default.
• W2801679898 hasConcept C2779376020 @default.
• W2801679898 hasConcept C2780930700 @default.
• W2801679898 hasConcept C2780940725 @default.
• W2801679898 hasConcept C540031477 @default.
• W2801679898 hasConcept C55493867 @default.
• W2801679898 hasConcept C58245268 @default.
• W2801679898 hasConcept C62231903 @default.
• W2801679898 hasConcept C71924100 @default.
• W2801679898 hasConcept C7836513 @default.
• W2801679898 hasConcept C86803240 @default.
• W2801679898 hasConcept C98274493 @default.
• W2801679898 hasConceptScore W2801679898C126322002 @default.
• W2801679898 hasConceptScore W2801679898C139940330 @default.
• W2801679898 hasConceptScore W2801679898C150903083 @default.
• W2801679898 hasConceptScore W2801679898C164705383 @default.
• W2801679898 hasConceptScore W2801679898C178790620 @default.
• W2801679898 hasConceptScore W2801679898C178853913 @default.
• W2801679898 hasConceptScore W2801679898C185592680 @default.
• W2801679898 hasConceptScore W2801679898C190283241 @default.
• W2801679898 hasConceptScore W2801679898C20251656 @default.

• next